Lanthionine synthetase components C-like 2 increases cellular Sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanismPARK, Soyeon; JAMES, C. David.Cancer research (Baltimore). 2003, Vol 63, Num 3, pp 723-727, issn 0008-5472, 5 p.Article

The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated GlioblastomasGINI, Beatrice; ZANCA, Ciro; SHAOJUN ZHU et al.Clinical cancer research (Print). 2013, Vol 19, Num 20, pp 5722-5732, issn 1078-0432, 11 p.Article

Altered molecular pathways in gliomas: An overview of clinically relevant issuesRAO, Ravi D; JAMES, C. David.Seminars in oncology. 2004, Vol 31, Num 5, pp 595-604, issn 0093-7754, 10 p.Article

Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomasJUN LI; PERRY, Arie; JAMES, C. David et al.Neurology. 2001, Vol 56, Num 7, pp 885-890, issn 0028-3878Article

Genetic analysis of early- versus late-stage ovarian tumorsSHRIDHAR, Viji; LEE, John; KEENEY, Gary et al.Cancer research (Baltimore). 2001, Vol 61, Num 15, pp 5895-5904, issn 0008-5472Article

Challenges in drug delivery to tumors of the central nervous system: An overview of pharmacological and surgical considerationsSERWER, LauraP; JAMES, C. David.Advanced drug delivery reviews. 2012, Vol 64, Num 7, pp 590-597, issn 0169-409X, 8 p.Article

Reversing HOXA9 Oncogene Activation by P13K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human GlioblastomaCOSTA, Bruno M; SMITH, Justin S; REIS, Rui M et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 2, pp 453-462, issn 0008-5472, 10 p.Article

Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaPRADOS, Michael D; CHANG, Susan M; FEDOROFF, Anne et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 579-584, issn 0732-183X, 6 p.Article

Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma PatientsLU, Kan V; SHAOJUN ZHU; LEE, Yohan et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 17, pp 6889-6898, issn 0008-5472, 10 p.Article

Gliomas: advances in molecular analysis and characterization. CommentaryBOUDREAU, Christine R; YANG, Isaac; LIAU, Linda M et al.Surgical neurology. 2005, Vol 64, Num 4, pp 286-294, issn 0090-3019, 9 p.Article

Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomasGALANIS, Evanthia; BATEMAN, Andrew; JOHNSON, Kimberly et al.Human gene therapy. 2001, Vol 12, Num 7, pp 811-821, issn 1043-0342Article

Mutational Inactivation of STAG2 Causes Aneuploidy in Human CancerSOLOMON, David A; KIM, Taeyeon; SAMUELS, Yardena et al.Science (Washington, D.C.). 2011, Vol 333, Num 6045, pp 1039-1043, issn 0036-8075, 5 p.Article

Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood : results from the Children's Cancer Group 945 cohortPOLLACK, Ian F; HAMILTON, Ronald L; JAMES, C. David et al.Journal of neurosurgery. Pediatrics. 2006, Vol 105, Num 5, pp 418-424, issn 1933-0707, 7 p.Article

Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificityALLEN, Cory; VONGPUNSAWAD, Sompong; UHM, Joon H et al.Cancer research (Baltimore). 2006, Vol 66, Num 24, pp 11840-11850, issn 0008-5472, 11 p.Article

Correlation of the response of recurrent malignant gliomas treated with interferon a with tumor interferon a gene contentOLSON, Jeffrey J; JAMES, C. David; LAWSON, David et al.International journal of oncology. 2004, Vol 25, Num 2, pp 419-427, issn 1019-6439, 9 p.Article

PS6K amplification characterizes a small subset of anaplastic meningiomasCAI, Dan X; JAMES, C. David; SCHEITHAUER, Bernd W et al.American journal of clinical pathology. 2001, Vol 115, Num 2, pp 213-218, issn 0002-9173Article

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug effluxERLICHMAN, Charles; BOERNER, Scott A; KAUFMANN, Scott H et al.Cancer research (Baltimore). 2001, Vol 61, Num 2, pp 739-748, issn 0008-5472Article

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiformeSMITH, Justin S; TACHIBANA, Issei; BUCKNER, Jan C et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 16, pp 1246-1256, issn 0027-8874Article

Noninvasive Detection of Target Modulation following Phosphatidylinositol 3-Kinase Inhibition Using Hyperpolarized ¹³C Magnetic Resonance SpectroscopyWARD, Christopher S; VENKATESH, Humsa S; JAMES, C. David et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 4, pp 1296-1305, issn 0008-5472, 10 p.Article

Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN : Laboratory investigationCHI, John H; PANNER, Amith; CACHOLA, Kristine et al.Journal of neurosurgery. 2008, Vol 108, Num 2, pp 299-303, issn 0022-3085, 5 p.Article

Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma TumorsJOO MI YI; TSAI, Hsing-Chen; LATERRA, John et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 19, pp 8094-8103, issn 0008-5472, 10 p.Article

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaPELLOSKI, Christopher E; BALLMAN, Karla V; WOO, Shiao Y et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2288-2294, issn 0732-183X, 7 p.Article

Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathwaysREMSTEIN, Ellen D; KURTIN, Paul J; JAMES, C. David et al.The American journal of pathology. 2002, Vol 161, Num 1, pp 63-71, issn 0002-9440Article

Small cell architecture: A histological equivalent of EGFR amplification in glioblastoma multiforme?BURGER, Peter C; PEARL, Dennis K; ALDAPE, Kenneth et al.Journal of neuropathology and experimental neurology. 2001, Vol 60, Num 11, pp 1099-1104, issn 0022-3069Article

17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGMA1B genesWU, Guo-Jun; SINCLAIR, Colleen S; PAAPE, John et al.Cancer research (Baltimore). 2000, Vol 60, Num 19, pp 5371-5375, issn 0008-5472Article